Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7‐kb β‐globin gene deletion Journal Articles uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • AbstractA young woman originally from Cape Verde islands presented with mild sickle cell disease. Her blood counts and hemoglobin analysis results initially suggested that she might be either homozygous for the sickle cell hemoglobin (Hb S) with concomitant α‐thalassemia, or compound heterozygous for Hb S and β0‐thalassemia, deletional δβ‐thalassemia or hereditary persistence of fetal hemoglobin (HPFH). We utilized a novel polymerase chain reaction (PCR)‐based screening technique and found a hitherto unrecognized 7.7‐kb deletion, starting from the HBB IVSII to 3′ downstream of the β‐globin gene. This diagnostic approach can be applied to decipher other similar deletional mutations. This is the second known deletion that removes the 3′‐end but preserves the integrity of the 5′‐end of the β‐globin gene. Furthermore, the identification of the deletion allows proper genetic counseling for affected families.


  • Andersson, B Anders R
  • Wering, Mikaela EL
  • Luo, Hong‐Yuan
  • Basran, Raveen K
  • Steinberg, Martin H
  • Smith, Hedy P
  • Chui, David Hing-kwei

publication date

  • January 2007